BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:20 PM
 | 
Oct 23, 2012
 |  BC Extra  |  Clinical News

ALK-Abello gains on allergy data

ALK-Abello A/S (CSE:ALK-B) gained DKK20.50 to DKK383.50 on Tuesday after its grass Allergy Immunotherapy Tablet (AIT) met the primary endpoint in a Phase III...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >